Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by fredgoodwinsonon Jun 22, 2020 11:33am

129 Views

Post# 31176663

RE:RE:RE:Opioids

This enforced moratorium on progess for the drugs of its`potential competitors must be some kind of heaven for Big Pharma - would be very surprised if there is any hurry to re-open Trials in the States.

Best hope here remains UHN for NMIBC and an early start for the first Rutherrin trial in Canada.

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta